Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi Journal Article


Authors: Gerami, P.; Wass, A.; Mafee, M.; Fang, Y.; Pulitzer, M. P.; Busam, K. J.
Article Title: Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi
Abstract: Nevoid melanoma may resemble benign compound or intradermal nevi by their silhouette and profile on low power. Higher power usually reveals nuclear atypia, confluence of cells, incomplete maturation and dermal mitotic activity. However, to some extent all of these features maybe seen in benign compound or intradermal nevi and no single criteria can be used to differentiate nevoid melanoma from a benign nevus. The distinction can be particularly problematic in nevi that show mitotic activity and we have noted a recent trend in diagnosis of melanocytic neoplasms with dermal mitosis as nevoid melanoma despite the presence of normal maturation in the dermis and lack of significant nuclear atypia. Therefore in this study we evaluated 10 nevoid melanomas, 4 of which resulted in metastasis and 10 mitotically active nevi with fluorescence in situ hybridization targeting key chromosomal loci previously shown to effectively discriminate been malignant and benign melanocytic neoplasms. All 10 nevoid melanomas showed copy number abnormalities by fluorescence in situ hybridization in either chromosome 6 or 11 while none of the 10 mitotically active nevi did. The results demonstrate that fluorescence in situ hybridization targeting key chromosomal loci on chromosomes 6 and 11 can be effective in discriminating nevoid melanomas from mitotically active nevi. Additionally, our study presents further evidence that dermal mitoses alone without other diagnostic features such as nuclear atypia and lack of maturation does not constitute sufficient evidence alone for a diagnosis of melanoma. © 2009 by Lippincott Williams & Wilkins.
Keywords: dna binding protein; genetics; dna-binding proteins; clinical trial; united states; comparative study; mitosis; in situ hybridization, fluorescence; melanoma; metastasis; nevus; skin neoplasms; diagnosis, differential; differential diagnosis; transcription factor; pathology; dermis; time; time factors; transcription factors; gene expression regulation; chromosome aberration; gene expression regulation, neoplastic; skin tumor; fluorescence in situ hybridization; multicenter study; prediction and forecasting; predictive value of tests; chromosomes, human, pair 6; chromosome aberrations; cyclin d1; mitotically active nevi; nevoid melanoma; ccnd1 protein, human; protein c myb; rreb1 protein, human; chromosome 11; chromosome 6; chromosomes, human, pair 11; nevus, intradermal; proto-oncogene proteins c-myb
Journal Title: American Journal of Surgical Pathology
Volume: 33
Issue: 12
ISSN: 0147-5185
Publisher: Lippincott Williams & Wilkins  
Date Published: 2009-12-01
Start Page: 1783
End Page: 1788
Language: English
DOI: 10.1097/PAS.0b013e3181ba6db6
PUBMED: 19809275
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 3" - "Export Date: 30 November 2010" - "CODEN: AJSPD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Melissa P Pulitzer
    203 Pulitzer
  2. Klaus J Busam
    688 Busam
  3. Yuqiang Fang
    23 Fang